{
    "id": "0329",
    "question": "A 57-year-old woman is brought to the emergency department by ambulance for dysarthria and left-sided facial droop. She is accompanied by her son, who states that the patient had just returned home an hour ago from walking the dog when suddenly the patient stated she felt \u201cstrange.\u201d When her son asked her what was wrong, her speech was slurred and her \"face looked funny.\u201d The son quickly called an ambulance. The paramedic upon arrival noted that the patient had left-sided facial droop. Her medical history includes asthma and sickle cell disease. She takes hydroxyurea, uses oxycodone as needed for pain, and an albuterol inhaler as needed for shortness of breath. The patient\u2019s temperature is 97\u00b0F (36.1\u00b0C), blood pressure is 145/72 mmHg, pulse is 93/min, and respirations are 14/min with an oxygen saturation of 96% on room air. On physical examination, a left-sided facial droop is appreciated. She has trouble articulating her words, and her speech is garbled. She is put on 2 L of oxygen by nasal cannula. Labs are obtained and pending. Which of the following therapies is most likely indicated?",
    "options": {
        "A": "Alteplase",
        "B": "Exchange transfusion",
        "C": "Hydralazine",
        "D": "Warfarin"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To approach this case, we need to consider the patient's symptoms and medical history to determine the most likely diagnosis and appropriate treatment. The patient presents with sudden onset of dysarthria and left-sided facial droop, which suggests a possible stroke. The patient's history of sickle cell disease and use of hydroxyurea, a medication used to reduce the frequency of painful crises in sickle cell disease, is also relevant. However, the key to this case is the sudden onset of neurological symptoms, which is highly suggestive of a stroke. The patient's symptoms of slurred speech and left-sided facial droop are classic signs of a stroke, particularly a large vessel stroke. The patient's use of hydroxyurea does not directly influence the treatment of acute stroke. The patient's oxygen saturation is normal, which makes it less likely that her symptoms are due to hypoxia. The patient's blood pressure is elevated, which may be a sign of a stroke, but it is not the primary treatment for stroke. The patient's asthma and use of albuterol inhaler are not relevant to the acute management of stroke. The patient's temperature is normal, which makes it less likely that her symptoms are due to a vasculitic process. Considering the patient's symptoms and medical history, the most likely diagnosis is an ischemic stroke. The appropriate treatment for ischemic stroke is thrombolytic therapy, which is indicated in patients with acute ischemic stroke who meet specific criteria, including a high-risk stroke, a National Institutes of Health Stroke Scale (NIHSS) score of 5 or higher, and a lack of contraindications to thrombolytic therapy. Alteplase is a recombinant tissue plasminogen activator (tPA) that is FDA-approved for the treatment of acute ischemic stroke. It works by dissolving the blood clot that is causing the stroke. The patient's symptoms and medical history suggest that she meets the criteria for thrombolytic therapy, making alteplase the most appropriate therapy in this case. The other options, exchange transfusion and hydralazine, are not indicated in the treatment of ischemic stroke, and warfarin is an anticoagulant that is used to prevent stroke in patients with atrial fibrillation, not to treat acute stroke.\"} \"answer_choice\": \"A\"",
    "snippets": [],
    "scores": [],
    "execution_time": 59.271748304367065
}